Literature DB >> 16956368

A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins.

Kenneth P Holbourn1, Clifford C Shone, K R Acharya.   

Abstract

The ADP-ribosylating toxins (ADPRTs) are a family of toxins that catalyse the hydrolysis of NAD and the transfer of the ADP-ribose moiety onto a target. This family includes many notorious killers, responsible for thousands of deaths annually including: cholera, enterotoxic Escherichia coli, whooping cough, diphtheria and a plethora of Clostridial binary toxins. Despite their notoriety as pathogens, the ADPRTs have been extensively used as cellular tools to study and elucidate the functions of the small GTPases that they target. There are four classes of ADPRTs and at least one structure representative of each of these classes has been determined. They all share a common fold and several motifs around the active site that collectively facilitate the binding and transfer of the ADP-ribose moiety of NAD to their protein targets. In this review, we present an overview of the physiology and cellular qualities of the bacterial ADPRTs and take an in-depth look at the structural motifs that differentiate the different classes of bacterial ADPRTs in relation to their function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956368     DOI: 10.1111/j.1742-4658.2006.05442.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  64 in total

1.  Crystal structure of human ADP-ribose transferase ARTD15/PARP16 reveals a novel putative regulatory domain.

Authors:  Tobias Karlberg; Ann-Gerd Thorsell; Åsa Kallas; Herwig Schüler
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

2.  Sir2 deacetylases exhibit nucleophilic participation of acetyl-lysine in NAD+ cleavage.

Authors:  Brian C Smith; John M Denu
Journal:  J Am Chem Soc       Date:  2007-04-17       Impact factor: 15.419

Review 3.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

Review 4.  ADP-ribosyltransferases and poly ADP-ribosylation.

Authors:  Chao Liu; Xiaochun Yu
Journal:  Curr Protein Pept Sci       Date:  2015       Impact factor: 3.272

5.  Structure function analysis of an ADP-ribosyltransferase type III effector and its RNA-binding target in plant immunity.

Authors:  Byeong-ryool Jeong; Yan Lin; Anna Joe; Ming Guo; Christin Korneli; Huirong Yang; Ping Wang; Min Yu; Ronald L Cerny; Dorothee Staiger; James R Alfano; Yanhui Xu
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

6.  Characterization of Streptococcus pyogenes beta-NAD+ glycohydrolase: re-evaluation of enzymatic properties associated with pathogenesis.

Authors:  Joydeep Ghosh; Patricia J Anderson; Sukantha Chandrasekaran; Michael G Caparon
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

Review 7.  Novel bacterial ADP-ribosylating toxins: structure and function.

Authors:  Nathan C Simon; Klaus Aktories; Joseph T Barbieri
Journal:  Nat Rev Microbiol       Date:  2014-07-14       Impact factor: 60.633

8.  Structure and function of an ADP-ribose-dependent transcriptional regulator of NAD metabolism.

Authors:  Nian Huang; Jessica De Ingeniis; Luca Galeazzi; Chiara Mancini; Yuri D Korostelev; Alexandra B Rakhmaninova; Mikhail S Gelfand; Dmitry A Rodionov; Nadia Raffaelli; Hong Zhang
Journal:  Structure       Date:  2009-07-15       Impact factor: 5.006

Review 9.  Translocated effectors of Yersinia.

Authors:  Hiroyuki Matsumoto; Glenn M Young
Journal:  Curr Opin Microbiol       Date:  2009-02       Impact factor: 7.934

10.  Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr.

Authors:  Jennifer Baysarowich; Kalinka Koteva; Donald W Hughes; Linda Ejim; Emma Griffiths; Kun Zhang; Murray Junop; Gerard D Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.